GEM vs GEM+TS-1 for Advanced Pancreatic Cancer

NCT00514163 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

110

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Cancer

Interventions

DRUG: gemcitabine + S-1
DRUG: gemcitabine

Sponsor

Japan Clinical Cancer Research Organization